Oliver Hendricks

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .

Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment

A. Hansen, A. Loft, A. Jurik, 2023, The Journal of Rheumatology.